Moderna CEO reportedly expects coronavirus vaccine interim results in November

Moderna Chief Executive Officer Stéphane Bancel expects interim results from its Covid-19 vaccine trial in November and said the U.S government could give an emergency use nod in December, The Wall Street Journal reported on Monday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.